Assessment of pre-treatment cognitive performance in adult bone marrow or haematopoietic stem cell transplantation patients: A comparative study

European Journal of Cancer

Volumn 41, Issue 7, 2005, Pages 1007-1016

  Harder, Helena ^a   Van Gool, Arthur R ^a   Cornelissen, Jan J ^a   Duivenvoorden, Hugo J ^b   Eijkenboom, Wil M H ^a   Barge, Rene M Y ^c   Van Den Bent, Martin J ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Bone marrow transplantation; Fatigue; Haematological malignancies; Neuropsychological evaluation; Psychological functioning; Quality of life

Indexed keywords

ADULT; ANXIETY; ARTICLE; BONE MARROW TRANSPLANTATION; CANCER THERAPY; COGNITION; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; DEPTH PERCEPTION; EMOTION; FATIGUE; FEMALE; HEMATOLOGIC MALIGNANCY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL PERFORMANCE; NEUROPSYCHOLOGICAL TEST; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR ACTIVITY; QUALITY OF LIFE; QUESTIONNAIRE; RELIABILITY; SOCIAL STATUS; VISUAL MEMORY;

EID: 18044391262     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2005.01.015     Document Type: Article

References (44)

1. C. Anderson-Hanley, M.L. Sherman, and R. Riggs Neuropsychological effects of treatment for adults with cancer: a meta-analysis and review of literature J Int Neuropsychol Soc 9 2003 967 982
2. P. Parth, W.P. Dunlap, and R.S. Kennedy Motor and cognitive testing of bone marrow transplant patients after chemoradiotherapy Percept Motor Skills 68 1989 1227 1241
3. M.A. Andrykowski, E.M. Altmaier, and R.L. Barnett Cognitive dysfunction in adult survivors of allogeneic marrow transplantation: relationship to dose of total body irradiation Bone Marrow Transplant 6 1990 269 276
4. M.A. Andrykowski, F.A. Schmitt, and M.E. Gregg Neuropsychologic impairment in adult bone marrow transplant candidates Cancer 70 1992 2288 2297
5. C.A. Meyers, M. Weitzner, and K. Byrne Evaluation of the neurobehavioral functioning of patients before, during and after bone marrow transplantation J Clin Oncol 12 1994 820 826
6. T.A. Ahles, D.M. Tope, and C. Furstenberg Psychologic and neuropsychologic impact of autologous bone marrow transplantation J Clin Oncol 14 1996 1457 1462
7. C.S. Padovan, T.A. Yoursy, and M. Schleuning Neurological and neuroradiological findings in long-term survivors of allogeneic bone marrow transplantation Ann Neurol 43 1998 627 633
8. F. Wenz, S. Steinvorth, and F. Lohr Acute central nervous system (CNS) toxicity of total body irradiation (TBI) measured using neuropsychological testing of attention functions Int J Radiat Oncol Biol Phys 44 1999 891 894
9. M. Peper, S. Steinvorth, and P. Schraube Neurobehavioral toxicity of total body irradiation: a follow-up in long-term survivors Int J Radiat Oncol Biol Phys 46 2000 303 311
10. F. Wenz, S. Steinvorth, and F. Lohr Prospective evaluation of delayed central nervous system (CNS) toxicity of hyperfractionated total body irradiation (TBI) Int J Radiat Oncol Biol Phys 48 2000 1497 1501
11. H. Harder, J.J. Cornelissen, and A.R. Van Gool Cognitive functioning and quality of life in long-term adult survivors of bone marrow transplantation Cancer 95 2002 183 192
12. P. Sostak, C.S. Padovan, and T.A. Yoursy Prospective evaluation of neurological complications after allogeneic bone marrow transplantation Neurology 60 2003 842 848
13. N. Gokbuget, and D. Hoelzer Recent approaches in acute lymphoblastic leukemia in adults Rev Clin Exp Hematol 6 2002 114 141
14. F.B. Hagemeister Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue Cancer Chemother Pharmacol 49 2002 13 20
15. R.L. Soutar, and D.J. King Bone marrow transplantation BMJ 310 1995 31 36
16. M. Nucci, F. Andrade, and A. Vigorito Infectious complications in patients randomized to receive bone marrow or peripheral blood transplantation Transpl Infect Dis 5 2003 167 173
17. D.A. Karnofsky, and J.H. Burchenal The clinical evaluation of chemotherapeutic agents in cancer C. McLeod Evaluation of Chemotherapeutic Agents 1949 Columbia University Press New York 191 205
18. J.L. Mulder, R. Dekker, and P.H. Dekker Handleiding Verbale Leer en Geheugen Test 1996 Swets & Zeitlinger Lisse
19. J.E. Meyers, and K.R. Meyers Rey Complex Figure Test and Recognition Trial. Professional Manual 1995 Psychological Assessment Resources Inc. Odessa
20. A.L. Benton The Revised Visual Retention Test 1974 The Psychological Corporation New York
21. J.Th. Snijders, F. Luteijn, and F.A.E. van der Ploeg Handleiding Groninger Intelligentie Test 1983 Swets & Zeitlinger Lisse
22. D. Wechsler Manual for the Wechsler Adult Intelligence Scale 1955 The Psychological Corporation New York
23. J.R. Stroop Studies of interference in serial verbal reactions J Exp Psychol 18 1935 634 662
24. A. Bouma, J.L. Mulder, and J. Lindeboom Neuropsychologische Diagnostiek, Handboek first edn. 1996 Swets & Zeitlinger Lisse
25. R.M. Reitan Validity of the Trail Making Test as an indication of organic brain damage Percept Motor Skills 8 1958 271 276
26. R. Brickenkamp Test d2. Aufmerksamkeitsbelastungstest. Handanweisung 1978 Hochrefe Gottingen
27. M.D. Lezak Neuropsychological Assessment 1995 Oxford University Press Oxford
28. H.A.M. Middelkoop, L.J. Vink, and J.B.K. Lanser Movement initiation and execution times in the study of human cognition and motor performance: differential and significant effects of sex and age D. Beersma Dutch Society for Sleep-wake Research in The Netherlands 1996 Uitgeverij Elinkwijk Utrecht 107 110
29. B. Schmandt, J. Lindeboom, and F. van Harskamp Nederlandse Leestest voor Volwassenen Handleiding 1992 Swets & Zeitlinger Lisse
30. D.E. Broadbent, P.F. Cooper, P. FitzGerald, and K.R. Parkes The Cognitive Failure Questionnaire (CFQ) and its correlates Br J Clin Psychol 21 1982 1 16
31. A.S. Zigmond, and R.P. Snaith The hospital anxiety and depression scale Acta Psychiatry Scand 67 1983 361 370
32. B.T. Carroll, R.G. Kathol, and R. Noyes Screening for depression and anxiety in cancer patients using the Hospital Anxiety and Depression Scale Gen Hosp Psychiatry 15 1993 69 74
33. M.J. Horowitz, N. Wilner, and W. Alvarez Impact of event scale: a measure of subjective stress Psychosom Med 41 1979 209 218
34. E.M.A. Smets, B. Garssen, and B. Bonke The multidimensional fatigue inventory (MFI) psychometric qualities of an instrument to assess fatigue J Psychosom Res 39 1995 315 325
35. N.K. Aaronson, S. Ahmedzi, and B. Bergman The EORTC QLQ-C30: a quality of life instrument for use in international clinical trials in oncology J Natl Cancer Inst 85 1993 365 376
36. P.M. Fayers, N.K. Aaronson, and K. Bjordal EORTC QLQ-C30 Scoring Manual 1995 Quality of Life Unit, EORTC Data Centre Brussels
37. M. Watson, R. Zittoun, and E. Hall A modular questionnaire for the assessment of long-term quality of life in leukemia: the MRC/EORTC QLQ-LEU Qual Life Res 5 1996 15 19
38. D. Strauss On Miettinnen's multivariate confounder score J Clin Epidemiol 51 1998 233 236
39. R.B. Weiss Adverse events of treatments V.J. De Vita S. Hellman S.A. Rosenberg Cancer: Principles and Practice of Oncology sixth edn. 2001 Lippincott, Wiliams, and Wilkins Philadelphia 2964 2968
40. C.B. Shields, G.H. Raque, and P.K. Gardner Neurologic aspects of breast cancers W.L. Donegan J.S. Spratt Cancer of the Breast 1995 WB Saunders Co. Philadelphia 717 727
41. T.A. Ahles, A.J. Saykin, and C.T. Furstenberg Neuropsychologic impact of standard-dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma J Clin Oncol 20 2002 485 493
42. E.S. Brown, D.J. Woolston, and A. Frol Hippocampal volume, spectroscopy, cognition, and mood in patients receiving corticosteroid therapy Biol Psychiatry 55 2004 538 545
43. H. Harder, H. Holtel, and J.E.C. Bromberg Cognitive status and quality of life after treatment for primary CNS lymphoma Neurology 62 2004 544 547
44. M.A. Pavol, C.A. Meyers, and J.L. Rexer Pattern of neurobehavioral deficits associated with interferon alfa therapy for leukemia Neurology 45 1995 947 950